$1.45
0.01[0.69%]
At close: May 31
$1.45
0[0.00%]
After Hours: 7:11AM EDT
Avrobio
(NASDAQ:AVRO)Avrobio Stock (NASDAQ:AVRO), Analyst Ratings, Price Targets, Predictions
Avrobio Inc has a consensus price target of $6, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Mizuho, Wells Fargo, and Wedbush on December 18, 2023, July 13, 2023, and July 12, 2023. With an average price target of $2 between Mizuho, Wells Fargo, and Wedbush, there's an implied 37.93% upside for Avrobio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
Wells Fargo
Wedbush
Needham
BTIG
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Avrobio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 12/18/2023 | Buy Now | 37.93% | Mizuho | Uy Ear | $5 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 07/13/2023 | Buy Now | 37.93% | Wells Fargo | Yanan Zhu | $2.5 → $2 | Maintains | Overweight | Get Alert |
| 07/12/2023 | Buy Now | 37.93% | Wedbush | David Nierengarten | → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 03/24/2023 | Buy Now | 244.83% | Mizuho | Uy Ear | $6 → $5 | Maintains | Buy | Get Alert |
| 03/24/2023 | Buy Now | 313.79% | Needham | Gil Blum | → $6 | Reiterates | → Buy | Get Alert |
| 12/08/2022 | Buy Now | 175.86% | BTIG | Yun Zhong | → $4 | Upgrade | Neutral → Buy | Get Alert |
| 05/17/2022 | Buy Now | 313.79% | Needham | Gil Blum | $8 → $6 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 175.86% | Barclays | Gena Wang | $6 → $4 | Maintains | Overweight | Get Alert |
| 01/06/2022 | Buy Now | 313.79% | Mizuho | Uy Ear | $28 → $6 | Maintains | Buy | Get Alert |
| 01/05/2022 | Buy Now | 313.79% | Barclays | Gena Wang | $22 → $6 | Maintains | Overweight | Get Alert |
| 01/05/2022 | Buy Now | 106.9% | Morgan Stanley | Michael Ulz | $7 → $3 | Maintains | Equal-Weight | Get Alert |
| 01/05/2022 | Buy Now | — | BTIG | Yun Zhong | — | Downgrade | Buy → Neutral | Get Alert |
| 01/05/2022 | Buy Now | 451.72% | Needham | Gil Blum | $28 → $8 | Maintains | Buy | Get Alert |
| 11/19/2021 | Buy Now | 382.76% | Morgan Stanley | Michael Ulz | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/12/2021 | Buy Now | 1624.14% | Morgan Stanley | David Lebowitz | — | Maintains | Overweight | Get Alert |
| 07/16/2021 | Buy Now | 1900% | Morgan Stanley | David Lebowitz | — | Maintains | Overweight | Get Alert |
| 06/15/2021 | Buy Now | 1486.21% | BTIG | Yun Zhong | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Avrobio (AVRO)?
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Mizuho on December 18, 2023. The analyst firm set a price target for $2.00 expecting AVRO to rise to within 12 months (a possible 37.93% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Avrobio (AVRO)?
The latest analyst rating for Avrobio (NASDAQ: AVRO) was provided by Mizuho, and Avrobio downgraded their neutral rating.
When was the last upgrade for Avrobio (AVRO)?
The last upgrade for Avrobio Inc happened on December 8, 2022 when BTIG raised their price target to $4. BTIG previously had a neutral for Avrobio Inc.
When was the last downgrade for Avrobio (AVRO)?
The last downgrade for Avrobio Inc happened on December 18, 2023 when Mizuho changed their price target from $5 to $2 for Avrobio Inc.
When is the next analyst rating going to be posted or updated for Avrobio (AVRO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avrobio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avrobio was filed on December 18, 2023 so you should expect the next rating to be made available sometime around December 18, 2024.
Is the Analyst Rating Avrobio (AVRO) correct?
While ratings are subjective and will change, the latest Avrobio (AVRO) rating was a downgraded with a price target of $5.00 to $2.00. The current price Avrobio (AVRO) is trading at is $1.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.